Evidence map›Paper›PMID 18299398›Full record

ArticleThe Journal of experimental medicine2008

Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage.

Alan B Cantor, Hiromi Iwasaki, Yojiro Arinobu, Tyler B Moran, Hirokazu Shigematsu, Matthew R Sullivan, Koichi Akashi, Stuart H Orkin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Role of the pioneer transcription factor GATA2 in health and disease.Journal of molecular medicine (Berlin, Germany) · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. The zebrafish: A fintastic model for hematopoietic development and disease.Wiley interdisciplinary reviews. Developmental biology · 2018
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Alan B CantorDivision of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA 02115, USA. alan.cantor@childrens.harvard.edu
Hiromi Iwasaki
Yojiro Arinobu
Tyler B Moran
Hirokazu Shigematsu
Matthew R Sullivan
Koichi Akashi
Stuart H Orkin
Boston Children's Hospital · USHarvard University · USKyushu University Hospital · JP

Funding

Proteomic Study of Megakaryocyte Transcriptional ControlR01HL075705 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI CANTOR, ALAN B. · 2004 to 2007
$1.4M
FOG1 AND HEMATOPOIESISK08CA082175 · NCI · CHILDREN'S HOSPITAL BOSTON · PI CANTOR, ALAN B. · 1999 to 2003
$500k
Howard Hughes Medical InstituteNCI NIH HHS K08 CA82175NHLBI NIH HHS R01 HL075705
6 · The paper itself

Abstract

The zinc finger transcription factor GATA-1 requires direct physical interaction with the cofactor friend of GATA-1 (FOG-1) for its essential role in erythroid and megakaryocytic development. We show that in the mast cell lineage, GATA-1 functions completely independent of FOG proteins. Moreover, we demonstrate that FOG-1 antagonizes the fate choice of multipotential progenitor cells for the mast cell lineage, and that its down-regulation is a prerequisite for mast cell development. Remarkably, ectopic expression of FOG-1 in committed mast cell progenitors redirects them into the erythroid, megakaryocytic, and granulocytic lineages. These lineage switches correlate with transcriptional down-regulation of GATA-2, an essential mast cell GATA factor, via switching of GATA-1 for GATA-2 at a key enhancer element upstream of the GATA-2 gene. These findings illustrate combinatorial control of cell fate identity by a transcription factor and its cofactor, and highlight the role of transcriptional networks in lineage determination. They also provide evidence for lineage instability during early stages of hematopoietic lineage commitment.

Indexed as

AnimalsBone Marrow CellsCell DifferentiationEmbryonic Stem CellsGATA1 Transcription FactorGATA2 Transcription FactorMaleMast CellsMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsMice, TransgenicMultipotent Stem CellsNuclear ProteinsTranscription FactorsGata1 protein, mouseGATA1 Transcription FactorGata2 protein, mouseGATA2 Transcription FactorNuclear ProteinsTranscription FactorsZfpm1 protein, mouse

Identifiers

PMID18299398
PMCPMC2275384
OpenAlexW2112344820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.